Coluracetam

CAS No. 135463-81-9

Coluracetam( MKC-231 | BCI-540 )

Catalog No. M11445 CAS No. 135463-81-9

A nootropic agent that enhances high-affinity choline uptake.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 29 In Stock
25MG 45 In Stock
50MG 58 In Stock
100MG 68 In Stock
200MG Get Quote In Stock
500MG 161 In Stock
1G 237 In Stock

Biological Information

  • Product Name
    Coluracetam
  • Note
    Research use only, not for human use.
  • Brief Description
    A nootropic agent that enhances high-affinity choline uptake.
  • Description
    A nootropic agent that enhances high-affinity choline uptake; significantly improves the learning deficits in the Morris' water maze of AF64A-treated rats, do not produce any significant side effects (1-10 mg/kg); orally active.Alzheimer's Disease Phase 2 Discontinued.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    MKC-231 | BCI-540
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Other Targets
  • Research Area
    Neurological Disease
  • Indication
    Alzheimer Disease

Chemical Information

  • CAS Number
    135463-81-9
  • Formula Weight
    341.4042
  • Molecular Formula
    C19H23N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=C(NC1=C2C(OC(C)=C2C)=NC3=C1CCCC3)CN4C(CCC4)=O
  • Chemical Name
    1-Pyrrolidineacetamide, 2-oxo-N-(5,6,7,8-tetrahydro-2,3-dimethylfuro[2,3-b]quinolin-4-yl)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 1-BENZENESULFONYL-PI...

    ——

  • McN3716

    Inhibition of brain mitochondrial β-oxidation by McN3716 (Methyl palmoxirate, MEP) significantly reduces the levels of all measured HETE and epoxytrienoic acids (EET), nonenzymatic auto-oxidative metabolites of ARA.

  • Neuropeptide SF (hum...

    Neuropeptide SF human augments paraventricular corticotrophin-releasing hormone (CRH) release and increases adrenocorticotropic hormone (ACTH) and corticosterone levels in the plasma. Neuropeptide SF human play a physiologic role in the regulation of such circadian functions as the activity of motor centers and the HPA axis, through the release of CRH.